A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required surgical intervention, such as manipulation under anesthesia, according to ...

A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...

A new survey has found that Type 1 diabetes can affect everyday decisions for nearly a third of those diagnosed ...

A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...

has approved Susvimo ® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema (DME), a leading cause ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...